Once-daily insulin glargine versus 6-hour sliding scale regular insulin for control of hyperglycemia after a bariatric surgical procedure: A randomized clinical trial

Endocrine Practice

Volumn 13, Issue 3, 2007, Pages 225-231

  Datta, Swati ^a   Qaadir, Arshia ^a   Villanueva, Griselda ^a   Baldwin, David ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; DRUG DERIVATIVE; GLARGINE; INSULIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INTENSIVE CARE UNIT; MALE; MIDDLE AGED; OBESITY; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; STOMACH BYPASS;

ADULT; BLOOD GLUCOSE; FEMALE; GASTRIC BYPASS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; OBESITY; POSTOPERATIVE PERIOD;

EID: 34447573008     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.13.3.225     Document Type: Article

References (26)

1. Clement S, Braithwaite SS, Magee MF, et al (American Diabetes Association Diabetes in Hospitals Writing Committee). Management of diabetes and hyperglycemia in hospitals [errata in Diabetes Care. 2004;27:856 and Diabetes Care. 2004;27:1255]. Diabetes Care. 2004;27: 553-591.
2. Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125:1007-1021.
3. Golden SH, Peart-Vigilance C, Kao WH, Brancati FL. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care. 1999;22:1408-1414.
4. Pomposelli JJ, Baxter JK III, Babineau TJ, et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr. 1998;22:77-81.
5. McAlister FA, Majumdar SR, Blitz S, Rowe BH, Romney J, Marrie TJ. The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care. 2005;28:810-815.
6. Spelman DW, Russo P, Harrington G, et al. Risk factors for surgical wound infection and bacteraemia following coronary artery bypass surgery. Aust N Z J Surg. 2000;70: 47-51.
7. Gandhi GY, Nuttall GA, Abel MD, et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc. 2005;80:862-866.
8. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359-1367.
9. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients [erratum in Mayo Clin Proc. 2005;80:1101]. Mayo Clin Proc. 2004;79:992-1000.
10. Grey NJ, Perdrizet GA. Reduction in nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract. 2004;10(Suppl 2):46-52.
11. Quale WS, Seidler AJ, Brancati FL. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med. 1997;157:545-552.
12. Gearhart JG, Duncan JL III, Replogle WH, Forbes RC, Walley EJ. Efficacy of sliding-scale insulin therapy: a comparison with prospective regimens. Fam Pract Res J. 1994;14:313-322.
13. Sawin CT. Action without benefit: the sliding scale of insulin use. Arch Intern Med. 1997;157:489.
14. Baldwin D, Villanueva G, McNutt R, Bhatnagar S. Eliminating inpatient sliding-scale insulin: a reeducation project with medical house staff. Diabetes Care. 2005;28: 1008-1011.
15. Garber AJ, Moghissi ES, Bransome ED Jr, et al (American College of Endocrinology Task Force on Inpatient Diabetes and Metabolic Control). American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract. 2004;10 (Suppl 2):4-9.
16. American Diabetes Association. Standards of medical care in diabetes - 2006. Diabetes Care. 2006;29(Suppl 1): 4-42.
17. Hirsch IB. Insulin analogues. N Engl J Med. 2005;352: 174-183.
18. Riddle MC, Rosenstock J, Gerich J (Insulin Glargine 4002 Study Investigators). The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care. 2003;26:3080-3086.
19. Rosenstock J, Dailey G, Massi-Benedetti M, Fritsche A, Lin Z, Salzman A. Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes. Diabetes Care. 2005;28:950-955.
20. Dixon JB, Pories WJ, O'Brien PE, Schauer PR, Zimmet P. Surgery as an effective early intervention for diabesity: why the reluctance? Diabetes Care. 2005;28: 472-474.
21. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis [erratum in JAMA. 2005;293:1728]. JAMA. 2004;292:1724-1737.
22. Yeldandi RR, Lurie A, Baldwin D. Comparison of once-daily glargine insulin with twice-daily NPH/regular insulin for control of hyperglycemia in inpatients after cardiovascular surgery. Diabetes Technol Ther. 2006;8:609-616.
23. Levetan CS, Passaro M, Jablonski K, Kass M, Ratner RE. Unrecognized diabetes among hospitalized patients. Diabetes Care. 1998;21:246-249.
24. Greci LS, Kailasam M, Malkani S, et al. Utility of HbA(1c) levels for diabetes case finding in hospitalized patients with hyperglycemia. Diabetes Care. 2003;26: 1064-1068.
25. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978-982.
26. Abern M, Boland E, Rothenberg DM, Colombo JA, Baldwin J, Baldwin D. Intensive insulin therapy (IIT) after coronary artery bypass graft (CABG) surgery [abstract A116]. Diabetes. 2004;53(Suppl 2):492.